The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Imaging with [89Zr]Zr-DFO-SC16.56 anti-DLL3 antibody in patients with neuroendocrine tumors of the prostate: A phase 1/2, first-in-human trial.
 
Salomon Tendler
Patents, Royalties, Other Intellectual Property - DLL3 ANTIBODIES
 
Mark Dunphy
Patents, Royalties, Other Intellectual Property - Memorial Sloan Kettering Cancer Center holds the intellectual rights to PU-H71 and [124I]-PU-H71 (PCT/US06/03676, PCT/US2012/045861), which have been licensed to Samus Therapeutics. Dr. Dunphy has contributed to the patents and has received financial roya
 
Anuradha Gopalan
No Relationships to Disclose
 
Joseph O' Donoghue
No Relationships to Disclose
 
Serge Lyashchenko
Leadership - Evergreen Theragnostics
Stock and Other Ownership Interests - Evergreen Theragnostics
Consulting or Advisory Role - Evergreen Theragnostics; Solve Tx
 
Lisa Bodei
Consulting or Advisory Role - Wren Laboratories
Research Funding - AAA/Endocyte/Novartis (Inst); AAA/Endocyte/Novartis (Inst); Abdera Thereapeutics (Inst); Advanced Accelerator Applications/Novartis (Inst); Fusion Pharmaceuticals (Inst); ITM Isotope Technologies Munich (Inst); Molecular Targeting Technologies (Inst); POINT Biopharma (Inst); RayzeBio (Inst)
(OPTIONAL) Uncompensated Relationships - AAA/Endocyte/Novartis; Amgen; Clovis Oncology; Fusion Pharmaceuticals; Great Point Partners; IBA RadioPharma Solutions; ITM Isotope Technologies Munich; Molecular Targeting Technologies; POINT Biopharma; RayzeBio
 
Heiko Schöder
Patents, Royalties, Other Intellectual Property - Memorial Sloan Kettering, my employer, has received royalty payments from Telix Pharmaceuticals. (Inst)
 
Karen Autio
Honoraria - MashupMedia
Research Funding - Amgen (Inst); AstraZeneca (Inst); Janssen (Inst); Janux Therapeutics (Inst); Pfizer (Inst)
 
John Poirier
Consulting or Advisory Role - DISCO Pharmaceuticals
Patents, Royalties, Other Intellectual Property - JTP is an inventor on patents WO2021007371A1, WO2022153194A, and WO2023034557A1, and has received royalty payments from Memorial Sloan Kettering Cancer Center.
Travel, Accommodations, Expenses - DISCO Pharmaceuticals
 
Michael Morris
Employment - Memorial Sloan-Kettering Cancer Center
Stock and Other Ownership Interests - Doximity
Consulting or Advisory Role - Ambrx; Amgen; Arvinas; Blue Earth Diagnostics; Bristol-Myers Squibb/Celgene; Clarity Pharmaceuticals; Convergent Therapeutics; Core Medica; Curium Pharma; Daiichi; Exelixis; Flare Therapeutics; Fusion Pharmaceuticals; ITM Isotope Technologies Munich; Lantheus Medical Imaging; Mashup Media; Pfizer; POINT Biopharma; Progenics; Telix Pharmaceuticals; Transtherabio; Z-Alpha
Research Funding - Astellas Pharma (Inst); AstraZeneca (Inst); Janssen (Inst); Novartis (Inst)
Patents, Royalties, Other Intellectual Property - Telix Pharmaceuticals (Inst)
Travel, Accommodations, Expenses - Amgen; APCCC; AstraZeneca; Memorial Sloan-Kettering Cancer Center
(OPTIONAL) Uncompensated Relationships - Amgen; Bayer; Halda Therapeutics; Janssen Oncology; Novartis; Wren Laboraties
 
Charles Rudin
Consulting or Advisory Role - Abbvie; Amgen; AstraZeneca; Auron Therapeutics; Daiichi Sankyo/UCB Japan; DISCO; Earli; Genentech/Roche; Jazz Pharmaceuticals; Merck
Research Funding - Daiichi Sankyo (Inst); Merck (Inst); Roche/Genentech (Inst)
Patents, Royalties, Other Intellectual Property - Royalties related to licensing of anti-DLL3 antibodies.
 
Jason Lewis
Leadership - pHLIP
Stock and Other Ownership Interests - Alpha-9; Clarity Pharmaceuticals; Evergreen Theragnostics; pHLIP; Summit Biomedical Imaging; Telix Pharmaceuticals
Consulting or Advisory Role - Alpha-9; Clarity Pharmaceuticals; InhibRx; Precirix; Sanofi
Research Funding - Novartis
Patents, Royalties, Other Intellectual Property - Clarity Pharmaceuticals; Daiichi Sankyo; Elucida Oncology, Inc; Macrocyclics, Inc; Theragnostics, Ltd